COLUMN GROUP LLC Holdings

COLUMN GROUP LLC is an investment fund managing more than 451.82M US dollars. The largest holdings include NGM Biopharmaceuticals, Revolution Medicines and RAPT Therapeutics. In Q2 2022 the fund bought assets of total value of 3.12M US dollars and sold assets of total value of 594K US dollars.

$451.82M

portfolio value

-4.61%

quarter

-56.16%

1 year

COLUMN GROUP LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q3 2021	320139000	79994000
Q4 2021	-4846000	47251000
Q2 2022	3124000	594000

COLUMN GROUP LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 52.51% Portfolio value: 237.22M Avg. open price: $15.97 Current price: $5.6 P/L: -64.93% Bought +11.64% shares Q2 2022	share	52.51%	237.22M	$15.97	$5.6	-64.93%	Bought +11.64% shares Q2 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 19.98% Portfolio value: 90.27M Avg. open price: $24.62 Current price: $24.32 P/L: -1.20% Bought +4.16% shares Q3 2022	share	19.98%	90.27M	$24.62	$24.32	-1.20%	Bought +4.16% shares Q3 2022
Biotechnology RAPT Therapeutics, Inc. Portfolio share: 14.27% Portfolio value: 64.49M Avg. open price: $21.99 Current price: $16.53 P/L: -24.83% Bought +91.19% shares Q2 2022	share	14.27%	64.49M	$21.99	$16.53	-24.83%	Bought +91.19% shares Q2 2022
Biotechnology Tenaya Therapeutics, Inc. Portfolio share: 6.03% Portfolio value: 27.26M Avg. open price: N/A Current price: $2.42 P/L: N/A N/A Q3 2021	share	6.03%	27.26M	N/A	$2.42	N/A	N/A Q3 2021
Biotechnology Surrozen, Inc. Portfolio share: 4.13% Portfolio value: 18.68M Avg. open price: $7.08 Current price: $0.54 P/L: -92.37% Sold -1.77% shares Q2 2022	share	4.13%	18.68M	$7.08	$0.54	-92.37%	Sold -1.77% shares Q2 2022
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 2.53% Portfolio value: 11.41M Avg. open price: N/A Current price: $4.02 P/L: N/A Sold -25.17% shares Q4 2021	share	2.53%	11.41M	N/A	$4.02	N/A	Sold -25.17% shares Q4 2021
Biotechnology eFFECTOR Therapeutics, Inc. Portfolio share: 0.55% Portfolio value: 2.46M Avg. open price: N/A Current price: $0.43 P/L: N/A N/A Q3 2021	share	0.55%	2.46M	N/A	$0.43	N/A	N/A Q3 2021

Showing TOP 7 COLUMN GROUP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of COLUMN GROUP LLC?

The biggest position of the COLUMN GROUP LLC is NGM Biopharmaceuticals, Inc. (NGM) with 52.51% portfolio share worth of 237.23M US dollars.

Top 5 COLUMN GROUP's holdings represent 96.93% of the portfolio:

NGM Biopharmaceuticals, Inc. (NGM) – 52.51%
Revolution Medicines, Inc. (RVMD) – 19.98%
RAPT Therapeutics, Inc. (RAPT) – 14.27%
Tenaya Therapeutics, Inc. (TNYA) – 6.03%
Surrozen, Inc. (SRZN) – 4.13%

Who is the portfolio manager of COLUMN GROUP LLC?

The portfolio manager of the COLUMN GROUP LLC is .

What is the total asset value of the COLUMN GROUP LLC portfolio?

COLUMN GROUP LLC total asset value (portfolio value) is 451.82M US dollars.

Who is ?

is the portfolio manager of the COLUMN GROUP LLC.

What is (COLUMN GROUP LLC) fund performance?

COLUMN GROUP's quarterly performance is -4.61%, annualy -56.16%.

What is the COLUMN GROUP LLC CIK?

COLUMN GROUP's Central Index Key is 0001833486 .